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Abstract 
A method to functionalize cholecyst-derived extracellular matrix (CEM) with free 
amine groups was established in an attempt to improve its potential for tethering of 
bioactive molecules. CEM was incorporated with Generation-1 polyamidoamine (G1 
PAMAM) dendrimer by using N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide (EDC) 
and N-hydroxysuccinimide (NHS) crosslinking system.  The nature of incorporation of 
PAMAM dendrimer was evaluated using shrink temperature measurements, FTIR 
assessment, ninhydrin assay and swellability. The effect of PAMAM incorporation on 
mechanical and degradation properties of CEM were evaluated using uniaxial mechanical 
test and collagenase degradation assay, respectively. Ninhydrin assay and FTIR 
assessment confirmed the presence of increasing free amine groups with increasing 
quantity of PAMAM in dendrimer-incorporated CEM (DENCEM) scaffolds.  The 
amount of dendrimer used was found to be critical in controlling scaffold degradation, 
shrink temperature and free amine content. Cell culture studies showed that fibroblasts 
seeded on DENCEM maintained their metabolic activity and ability to proliferate in vitro. 
In addition, fluorescence cell staining and SEM analysis of cell-seeded DENCEM 
showed preservation of normal fibroblast morphology and phenotype. 
 
Introduction 
Intact extracellular matrices (ECM) have demonstrated potential as biomaterials 
in various tissue engineering and clinical applications.
1-3
 These ECM scaffolds provide a 
natural three-dimensional support to aid the initial mechanical requirements necessary to 
support damaged or excised tissue.
4-6
 In addition, ECM provides vital biological cues for 
cellular recognition which is essential for initial cellular attachment, subsequent cellular 
differentiation, in growth of vascular networks and secretion of new ECM requisite for 
eventual scaffold remodeling and tissue regeneration.
7,8
  
Certain bioactive molecules such as basic fibroblast growth factor (FGF-2), 
transforming growth factor-beta (TGF-ß) and epidermal growth factor (EGF) are 
intrinsically found in ECM.
9-12
 In fact, TGF-ß in ECM substrates have been shown to be 
biologically active even after processing and sterilisation.
13
 As an alternative to the 
present approach of utilizing endogenous growth factors found naturally in ECM, 
exogenous biomolecules could be strategically tethered and delivered via ECM substrates 
when a specific bioactive molecule is desired to provide a specific signal for guided 
tissue regeneration.
14-16
  
In an optimal scaffold, biological functionalities can be provided within the 
scaffold with the intent to guide tissue regeneration.
17,18
 This could be achieved by 
passive loading, entrapment or direct covalent binding onto functional groups within 
scaffolds.
19-21
 Reactive surface functionality of dendrimers make them an attractive 
candidate as a strategy to deliver bioactive molecules. Dendrimer can function both as a 
linker to the scaffold and a carrier of bioactive molecules. The dense functional groups 
terminated on surface of dendrimers can react with intrinsic functional groups in protein-
based scaffolds to form covalent binding. Conveniently in this way, scaffold stability can 
also be tailored by controlling the extent of crosslinking, which has the benefit of 
extending their in vivo life.
22,23
 Availability of multiple functional groups effectively 
amplifies the number of sites available for conjugation with exogenous bioactive 
molecules. A similar strategy using polypropyleneimine octaamine dendrimers has 
recently been employed to stabilize and biofunctionalize collagen intended for cornea 
replacement.
24,25
 Nevertheless, dendrimers have gained popularity as drug carriers in 
pharmaceutical research to improve the efficiency of drug delivery.
26-28
  
In this study, Generation 1 polyamidoamine (G1 PAMAM) dendrimer was used 
as a model dendrimer and incorporated into cholecyst-derived extracellular matrix 
(CEM), a novel intact extracellular matrix derived from the perimuscular subserosal 
connective tissue of porcine cholecysts developed in our laboratory.
4,29,30
 The influence 
of different quantity of PAMAM dendrimer on properties of resultant scaffolds was 
examined. The characteristics of the resultant scaffold were evaluated using shrink 
temperature measurement, FTIR, ninhydrin assay, uniaxial tensile testing, collagenase 
degradation assay, as well as in vitro cell studies to ascertain cell viability, proliferation 
and morphology.  
Experimental Section 
Materials and Reagents. All materials and reagents used in this study were 
purchased from Sigma Ireland Ltd. (Dublin, Ireland) unless otherwise stated. Fresh 
porcine cholecysts of market-weight pigs were obtained from a local abattoir (Sean Duffy 
Exports Ltd., Gort, Ireland) and transported in ice to the laboratory.  
Preparation of Scaffolds 
Isolation and Decellularization of CEM.  CEM isolation process was performed 
as previously described.
29
 Briefly, excess liver tissue was removed and bile fluid drained. 
The neck and fundus of the cholecyst were trimmed, followed by a longitudinal incision 
to obtain a flat sheet of tissue. The mucosa, lamina propria and muscularis layers were 
peeled from the luminal side, followed by a similar process to remove the serosal 
mesothelium and its underlying connective tissue from the abluminal side. Any residual 
elements were removed by mechanical delamination on both sides. A solution of 0.15% 
per-acetic acid and 4.8% ethanol solution in deionized water were used to decellularize 
the sheet of tissue for 30 min to obtain the final material. The final material which is 
referred to as CEM was washed and freeze-dried for storage (Virtis Advantage Freeze 
Dryer, Gardiner, NY). 
PAMAM Incorporation in CEM. To incorporate PAMAM dendrimer in CEM, the 
freeze dried CEM samples weighing about 0.1 g were first hydrated in 0.05 M of 2-
morpholinoethane sulfonic acid (MES) buffer (pH 5.3) for 30 min and then transferred to 
50 ml of pre-cooled MES buffer on ice, with or without PAMAM dendrimer. A range of 
PAMAM dendrimer was used (0, 0.35, 0.7, 2.1, 4.2, 6.3, 8.4 mmoles per mg of CEM 
samples) to vary the degree of dendrimer incorporation. After 30 min equilibration of 
CEM samples in dendrimer solution, 0.0066 mmoles of EDC (N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide) and NHS (N-hydroxysuccinimide) were 
added per mg of CEM (molar ratio EDC:NHS of 1:1). The pH was adjusted to 5.3 with 1 
N NaOH and/or 1 N HCl. Crosslinking was allowed to begin at 37 
o
C in an incubator for 
4 hours with intermittent shaking. At the end of the reaction, all resultant samples were 
washed in three changes of PBS, followed by deionized water and freeze-dried. The 
dendrimer incorporated CEM scaffolds were designated as DENCEM. DENCEM was 
followed by a numerical suffix indicating the initial feed concentration of PAMAM 
dendrimer. For example CEM scaffold incorporated with 0.35 mmol of dendrimer/mg of 
CEM is designated as DENCEM0.35. CEM cross-linked with EDC/NHS without 
dendrimer is designated as EDCxCEM. Non-cross-linked CEM is designated as CEM.  
Glutaraldehyde Crosslinked CEM. Glutaraldehyde crosslinking was used as 
negative control for cell culture studies, as previously described.
29
 Briefly, 0.4 g of CEM 
scaffolds were immersed in 30 ml of 0.625% (w/v) of glutaraldehyde in phosphate buffer 
(pH7.4) for 4 hours in room temperature. The samples (GAxCEM) were then washed in 
PBS followed by distilled water and freeze-dried. 
Characterization of Scaffolds 
Shrink Temperature (Ts). The Ts of the scaffolds were determined using 
differential scanning calorimetry (DSC, Model DSC-60, Shimadzu, Europe Ltd., 
Duisburg, Germany). Samples measuring approximately 5 mg were immersed in 
deionized water at 4 °C for 1 hour. Excess water was removed from the hydrated samples 
with filter paper. The moist samples were hermetically sealed in aluminum pans. A 
constant heating rate of 5 °C/ min was used (temperature range 25-110 °C). An empty 
aluminum pan was used as the reference pan. Ts was determined as the onset value of the 
occurring endothermic peak. The mean value and standard deviation of three independent 
measurements were obtained for each scaffold type. 
Infrared Spectroscopy. IR spectra were recorded at room temperature (26+1
o
C) in 
the mid infrared range (4000-400 cm
-1
) using attenuated total reflectance fourier 
transform infrared spectrometer, (ATR-FTIR) (FTIR-8300, Shimadzu Europe Ltd., 
Duisburg, Germany).  Typically, 50 scans were signal-averaged for a single spectrum at a 
resolution of ±8 cm
−1
 using a ZnSe crystal at an incident angle of 45°.  The spectra were 
analyzed using the Hyper-IR software (Shimadzu Europe Ltd., Duisburg, Germany) to 
obtain quantitative peak information. 
Ninhydrin Assay. For ninhydrin assay, about 2 mg of each freeze dried test 
scaffold was taken in separate 1.5 ml microcentrifuge tubes. To each tube was added 200 
ul of deionized water and 1 ml of ninhydrin solution (one part of 4% (w/v) ninhydrin in 
2-Ethoxyethanol and one part 200 mM citric acid with 0.16% (w/v) stannous chloride, pH 
5.0). The tubes were heated at 95 
o
C for 30 min on a heating block. A deep blue or purple 
color chromophore (Ruhemann's purple) was obtained. The tubes were cooled to room 
temperature and 250 ul of the cooled solution was added to 1 ml of 50% (v/v) 
isopropanol solution in water. This mixture was vortexed and the optical absorbance of 
the solution was recorded with a spectrophotometer (UV 1601 – Shimadzu Europe Ltd., 
Duisburg, Germany) at a wavelength of 570 nm. Glycine at various concentrations was 
used as standard. 
Scaffold Swelling. Approximately 8-10 mg dry weights (Wd) of each scaffold 
types were immersed in Dulbecco’s Modified Eagle’s Medium (DMEM) at 37oC. After 
24 hours, the scaffolds were dabbed lightly on a piece of absorbent paper to remove 
excess media. The wet weights (Ww) of the scaffolds were measured. Swelling ratio was 
calculated by using the formula: (Ww – Wd)/ Ww. 
Collagenase Degradation. Bacterial collagenase (Type II, from Clostridium 
histolyticum) (Sigma: C6885, EC 3.4.24.3) was dissolved in 0.1 M Tris-HCl buffer (pH 
7.4) containing 0.005 M CaCl2 and 0.05 mg/ml NaN3. A concentration of 10 units of 
collagenase per mg of scaffold was used. At fixed time points, the degradation process 
was stopped by snap freezing. The microtubes containing the remaining scaffold were 
centrifuged at 12,000 rpm for 15 min. The remaining pellet was repeatedly washed with 
distilled water and subsequently dried and weighed. 
Uniaxial Mechanical Testing. 10mm wide strips of each scaffold type were 
soaked in phosphate buffer saline (pH 7.4) for at least 10 min. The wet strips were 
mounted onto a Zwick mechanical test frame fitted with manual clamps (25mm apart).  
Five preload cycles (0.1 N upper force limit) were applied to each strips to precondition 
the samples before the final test to failure. After preconditioning, the strips were loaded 
to failure (100N static load cell, test speed 5mm/min).  Load/ extension data were logged 
throughout testing to failure, using a computer equipped with mechanical testing data 
acquisition and analysis software (testXpert v7.1).  These data were used to construct a 
load-deformation curve, from which the maximum load at failure (Fmax) was obtained.   
In order to grip the samples sufficiently but not damage them with the manual 
clamps, sandpaper was super-glued to the ends of the samples, with a 10 mm overlap on 
each side.  This allowed the samples to be clamped securely and concomitantly prevent 
them from slipping out of the clamps. 
The ultimate tensile strength (UTS) (Fmax /original cross-sectional area, N/mm
2
) 
and modulus of elasticity (from the relationship σ =Eε, where: σ is the stress, ε is the 
strain and E is the modulus of elasticity, N/mm
2
) and strain at UTS were then determined.  
Cell Studies  
Cell Seeding. Murine 3T3 fibroblast were cultured to confluence in T75 flask 
containing DMEM which was supplemented with 10% fetal bovine serum (FBS), 1% 
(v/v) penicillin-streptomycin, 1.25mg/L Amphotericin-B and 1% glutamine 200 mM. 
Freeze dried test scaffolds were cut to fit the base of a 24-well plate (12 mm diameter). 
The scaffolds were disinfected with 0.15% per-acetic acid in 4.8% ethanol solution for 10 
min and subsequently washed thoroughly with Hank’s Balanced Salt Solution (HBSS). 
The samples were then incubated in media for 1 hour in a 5% CO2 humidified incubator 
at 37
o
C prior to seeding. Each scaffold was seeded with a density of 20 000 cells per well. 
Media was changed every 24 hours.  
AlamarBlue
™
 Assay. The viability of 3T3 fibroblasts on the test scaffolds was 
studied by monitoring their metabolic activity using the AlamarBlue
™
 assay (Biosource 
International, CA). At 1, 3, and 7 days after seeding, all cell-seeded scaffolds were 
transferred to a fresh 24-well plate to exclude the possibility of contribution of cells 
which might have proliferate at the bottom of the well. The scaffolds were rinsed with 
HBSS and 700 ul of 10% (v/v) AlamarBlue
™
 reagent in HBSS was added to each well. 
After 1 h of incubation at 37
o
C, fluorescence was measured using a microplate 
fluorescence reader (FLx800, Bio-Tek Instruments, Inc., Vermont) at excitation and 
emission wavelengths of 528 and 590 nm. Non-crosslinked CEM, EDCxCEM, tissue 
culture polystyrene (TCP, empty wells) and 0.625% glutaraldehyde (GAxCEM) 
crosslinked samples were used as control scaffolds. 
Hoechst Assay. The proliferation of 3T3 fibroblasts on CEM scaffolds were 
studied by quantifying the DNA on the cell-seeded scaffolds using the calorimetric 
Hoechst assay (bis-benzimide 33258). A working solution (concentration of 1 ug/ ml) 
was made in Dulbecco’s Phosphate Buffered Saline (DPBS). At 3 and 6 days after 
seeding, the cell-seeded scaffolds were transferred to a fresh 24-well plate and 1 ml of 
water was added to each well. Three freeze-thaw cycles (freeze at -80 
o
C, thaw to room 
temperature) were used to lyse the cell membranes followed by gentle shaking to release 
DNA into solution. 40 ul of cell lysate was transferred from each well into a 96-well plate 
and 160 ul of Hoechst solution was added. The mixture was allowed to sit for 20 min in 
the dark and the fluorescence was measured at 355 nm (excitation) and 460 nm 
(emission) (Wallac Victor3, 1420 Multilabel Counter, Perkin Elmer Inc., Wellesley, MA, 
USA). Calf Thymus DNA (Sigma D-4764) was used as a standard. Non-crosslinked 
CEM, EDCxCEM and 0.625% glutaraldehyde crosslinked (GAxCEM) samples were 
used as control scaffolds. 
Cell Morphology - Scanning Electron Microscopy (SEM). Murine 3T3 fibroblasts 
were grown on CEM scaffolds for 7 days with changes in media every 24 hours. The cell-
seeded scaffolds were washed twice with HBSS. The scaffolds were fixed with 3% GA 
for 24 hours followed by a standard process of dehydration in graded ethanol and 
chemical drying with hexamethyldisilazane. The dried samples were gold-coated 
(Emitech K-550X Sputter Coater, Emitech Ltd., Ashford, Kent, UK). A low-voltage, high 
resolution SEM (S-4700 Hitachi Scientific Instruments, Berkshire, UK) was used to 
acquire micrographs of cells on the surface of CEM scaffolds.  
Cell Morphology - Fluorescent Staining. Scaffolds seeded with cells were fixed 
with 4% paraformaldehyde for 15 min. The cells were permeabilized with 0.2% Triton X-
100 and cell cytoskeleton stained with rhodamine phalloidin (Molecular Probes, Bio 
Sciences Ltd., Dublin, Ireland) using 1:100 dilution for 1 h at room temperature. Excess 
stain was rinsed using HBSS and 4',6-diamidino-2-phenylindole (DAPI, Vectashield 
Mounting Medium with DAPI, H-1500, Vector Laboratories, Peterborough, UK) was 
used to stain the nuclei of cells for 20 min. The stained cells on scaffolds were rinsed in 
HBSS and were examined under fluorescence light microscope (BX51 inverted 
microscope equipped with DP-70 photography system, Olympus Europe, Hamburg, 
Germany). ImagePro Plus 5.0 software (Media Cybenetics Inc., MD, USA) was used to 
acquire digital images from the microscope. 
Statistical Analysis.   Statistical differences between experimental groups was 
determined by one-way analysis of variance (ANOVA). Tukey’s test was used for post 
hoc multiple comparisons. T-test was used when data had only two independent groups. 
A p value of <0.05 was considered to be statistically significant. Data are reported as the 
mean ± SD. SPSS 14.0 software for Microsoft Windows was used for this statistical 
analysis. 
Results 
Characterization of Scaffolds. 
Shrink Temperature (Ts). Ts is a measure of the hydrothermal stability of collagen 
based scaffolds. The higher the shrink temperature, the higher the crosslinking.
31,32
 Figure 
1 illustrates the Ts results for CEM, EDCxCEM and DENCEM scaffolds. Crosslinking of 
CEM with 0.0066mM of EDC both in the presence and absence of amine dendrimer, 
significantly increased the shrink temperature. Compared to EDCxCEM, addition of 
increasing feed concentrations of amine dendrimer did not cause a continuous increase in 
shrink temperature of DENCEM samples. Small quantities of PAMAM increased the Ts, 
but only up to a feed concentration of 0.7 mmoles of PAMAM per mg CEM. Beyond this 
concentration lower Ts were observed and were significantly lower for DENCEM6.3 and 
DENCEM8.4.  
The initial increase in Ts from 70.0 ± 0.8
o
C for EDCxCEM to 72.7 ± 0.4
o
C for 
DENCEM0.7 can be attributed to the augmentation of crosslinking process by the multi 
amine dendrimer. In contrast, when dendrimer feed concentrations >0.7 mmoles per mg 
CEM were used, the drop in the Ts to 63.9 ± 0.8
o
C observed with DENCEM8.4 can be 
attributed to the excess dendrimer molecules competing for fewer available carboxyl 
groups causing less crosslink bridges and more pendant dendrimer molecules on CEM. 
Infrared Spectroscopy. IR spectroscopy involves the measurement of wavelength 
and intensity of absorption of IR light through excitation of molecular vibrations, which 
provides predictive information about changes in molecular structure of organic 
materials. ATR-FTIR has been a useful tool in the prediction of protein structure and 
crosslinking. The representative IR spectra of the test scaffolds in this study are shown in 
Figure 2A. All spectra were typical of that observed for proteins
33-35
 and it was difficult 
to distinguish any trends or changes in the spectra among the scaffold variants by naked 
eye. In order to analyze the spectra, quantitative peak information was obtained using the 
Hyper-IR software (Shimatzu, Japan). The absorption peak area ratios of the Amide I 
band at 1635cm
-1
 to that of free –COOH group at 1735cm-1 were determined and the 
ratios plotted as a function of dendrimer feed concentration (Figure 2B). The rationale 
behind the choice of the peaks 1635cm
-1
 and 1735cm
-1
 was that the amount of EDC 
activated –COOH groups available for reaction are constant because of the use of a fixed 
amount of EDC (0.0066 mmoles of EDC per mg CEM) in the preparation for all 
DENCEM samples. As a result, an increase in the 1635cm
-1
 to 1735cm
-1
 peak ratios 
would indicate the decrease in the free –COOH groups and the increase in amide 
linkages. The Amide I (1635 cm
-1
) to free –COOH (1735 cm-1) peak area ratio for 
DENCEM scaffolds increased with increasing dendrimer concentration until 4.2 mmoles 
and decreased with further increase in dendrimer concentration (Figure 2B).  
Ninhydrin Assay. Ninhydrin assay was used to quantitatively assess the amount of 
free amines present in the scaffolds.
36,37
 The results of the quantitative assessment of 
amine content using colorimetric ninhydrin assay are shown in Figure 3. EDC/ NHS 
crosslinking of CEM reduced the amount of free amine groups by amide bond formation 
with carboxyl groups. All DENCEM scaffolds showed significantly higher free amine 
groups when compared to both EDCxCEM and non-crosslinked CEM, with the exception 
of DENCEM0.35 compared to non-crosslinked CEM. Among the DENCEM scaffolds, 
the free amine content increased with increasing PAMAM dendrimer reaction feed 
concentration, indicating an increasing incorporation of free amine groups within the 
scaffold.  
Scaffold Swelling. The swelling ratio shows the hydrophilicity of the engineered 
constructs, as well as the ability to hold fluid and nutrients in both the in vitro and in vivo 
environments, factors which are important for cellullar infiltration and proliferation. 
Additionally, it represents a crude assessment of the extent of crosslinking as reported 
earlier.
38,39
 The swelling ratios for the scaffold variants of this study in DMEM media at 
37
o
C at 24 hours are presented in Figure 4. The non-crosslinked CEM control showed the 
highest swelling ratio. All DENCEM samples and EDCxCEM showed a statistically 
lower swelling ratio compared to non-crosslinked CEM indicating crosslinking of CEM 
scaffold. 
Collagenase Degradation. Collagenase degradation assay has been used to 
evaluate the resistance of collagen-based scaffolds against enzymatic degradation.
40,41
 
The percentage weight of scaffolds remaining after collagenase degradation as a function 
of time is shown in Figure 5. At 8 hours, EDCxCEM, DENCEM0.35 and DENCEM0.70 
scaffolds showed significantly higher resistance to degradation when compared to 
DENCEM4.2 and DENCEM8.4 scaffolds. DENCEM8.4 showed significant difference 
with all other scaffolds at 8 hours. As expected, non-crosslinked CEM control showed 
significantly lower remaining weight when compared to all other scaffolds at 8 hours. At 
48 hours, DENCEM0.35 and DENCEM0.7 still showed higher resistance to degradation 
when compared to other scaffolds and all samples were eventually degraded with no 
intact scaffold at 72 hours. 
Uniaxial Mechanical Testing. The ultimate tensile strength (UTS), modulus of 
elasticity and strain at UTS of CEM, EDCxCEM and DENCEM scaffolds are shown in 
Table 1. Crosslinking had no significant effect on the ultimate tensile strength of CEM. 
However, differences were observed for modulus of elasticity and strain at UTS of non-
crosslinked CEM from rest of the scaffold variants. The modulus of elasticity was 
significantly lower and strain at UTS significantly higher for EDCxCEM and DENCEM 
scaffolds compared to that observed for non-crosslinked CEM, with the exception of 
DENCEM0.35 for modulus of elasticity. Among EDCxCEM and DENCEM scaffolds no 
statistical differences were observed for both modulus of elasticity and strain at UTS, 
with the exception of DENCEM6.3, which showed a significantly higher strain at UTS. 
Cell Studies. 
AlamarBlue
™
 Assay. The results of the Alamar-Blue cell viability assay of 
fibroblasts seeded on CEM, EDCxCEM & DENCEM scaffolds compared to that on TCP 
(positive control) and GAxCEM (negative control) as measured by fluorescence optical 
density (OD) are shown in Figure 6. No statistical differences of AlamarBlue OD were 
observed on CEM, EDCxCEM, and DENCEM scaffolds compared to that on TCP, 
except a significantly higher OD for TCP at 3 days, whereas the ODs for all scaffolds at 
all time points were significantly higher than that on GAxCEM. From day 1 to day 7, 
there was a significant increase in AlamarBlue OD all test variants, with the exception of 
TCP and DENCEM0.35 between day 3 and day 7. In the case of GAxCEM, the OD 
decreased significantly after day 1. 
Hoechst Assay. Figure 7 shows the results of DNA content by Hoechst DNA 
assay. All scaffolds showed increased DNA content from day 3 to day 6, with the 
exception of GAxCEM. At day 3, DENCEM and EDCxCEM scaffolds showed 
significantly lower DNA content when compared to non-cross-linked CEM, except 
DENCEM6.3 which showed no difference. At day 6, the DENCEM6.3 showed 
significantly higher DNA content than all other scaffolds. Within the DENCEM samples, 
there was an increase in DNA content with increase in dendrimer feed concentration. 
Cell Morphology. The SEM and fluorescent light micrographs of scaffolds seeded 
with 3T3 fibroblast cells are shown in Figure 8. SEM images illustrate the surface 
morphology of confluent fibroblasts at 7 days on scaffolds. The morphology of 
fibroblasts on DENCEM (Figure 8e-h) and EDCxCEM (Figure 8c,d) scaffolds was 
similar to that observed on non-cross-linked CEM (Figure 8a,b). The fluorescent light 
micrographs showed intact cytoskeleton and nuclei of fibroblast cells. In less confluent 
areas, the fibroblasts could be seen to attach to each other and onto the three-dimensional 
surface of the scaffold fibers by elongated dendritic projections. The fibroblast cell bodies 
were typically either round, elongated, or star-shaped. Some cells showed an elongated 
appearance and attached along scaffold fibers (Figure 8d-f). 
Discussion 
In the present study, decellularized extracellular matrix from the porcine cholecyst 
was incorporated with G1 PAMAM dendrimers and the properties of the resultant 
scaffolds (DENCEM) were evaluated. In order to facilitate covalent attachment of the 
amine dendrimer onto the CEM scaffold, the carbodiimide (EDC/ NHS) crosslinking 
system was employed. The nature of incorporation of dendrimers was evaluated using 
shrink temperature, ATR-FTIR, ninhydrin and swelling studies. The effect of dendrimer 
incorporation on the mechanical, degradation and in vitro ability to support cell 
attachment, viability and proliferation properties of CEM were studied by uniaxial 
testing, collagenase degradation and in vitro cell culture, respectively.  
We had previously shown that the CEM scaffold contains approximately 80% of 
collagen and therefore, provides the required carboxyl and amine groups for amide 
crosslinking.
29
 Since the quantity of amine groups in collagen (34/1000 amino acid 
residues) is much lower than the quantity of carboxylic groups (120/1000 amino acid 
residues),
38
 it is desirable to provide additional amine groups in the form of amine 
dendrimer to augment the crosslinking process. Other research groups have investigated 
the effect of diamines as a method to improve compatibility and the extent of crosslinking 
in collagen.
42-44
 Our hypothesis for this study was that by using the multiamine PAMAM 
dendrimer, any unreacted amine groups in dendrimer can be utilized to tether bioactive 
molecules to improve chemical and biological functionalities of the scaffold.  
EDC/ NHS crosslinking involves the formation of amide bond between the 
carboxyl groups of glutamic or aspartic acid residues and amine groups.
38,45
 EDC is a 
water-soluble, zero-length crosslinker, whose reaction by-products can be eliminated by 
buffer/ water washing.
45
  Therefore, the EDC/NHS crosslinking does not leave any 
cytotoxic residues on the crosslinked matrix.
46-49
   
The EDC crosslinker concentration used in current experiments was kept constant 
at 0.0066 mmoles per mg of CEM and the amount of PAMAM dendrimer varied. The 
choice of 0.0066 mmoles of EDC/NHS per mg of scaffold was based on our earlier study. 
50
 At this concentration, the in vitro collagenase degradation time of CEM was prolonged, 
while maintaining degradability over an extended period of time, and any higher 
concentrations of EDC/ NHS resulted in total inhibition of CEM degradation by 
collagenase enzyme.
50
 In the present study, setting the EDC crosslinking concentration 
constant allowed us to study the effect of varying dendrimer concentration on the 
properties of CEM. 
The current study demonstrated the critical role played by the incorporation of 
varied feed concentration of PAMAM dendrimer on the properties of the resulting CEM 
scaffolds (DENCEM). G1 PAMAM dendrimer is a multifunctional (eight free amines per 
molecule) chemical agent, which was used as an adjunct to the EDC/ NHS crosslinking 
of CEM. In order to form effective bridging crosslinks, each dendrimer molecules must 
form at least two amide bonds to bridge polypeptides. An initial increase of amine groups 
of PAMAM allows more bridging crosslinks formation with the carboxyl groups in CEM. 
When higher or excess quantity of PAMAM dendrimer was used, competition for 
carboxyl groups occurred, leading to less bridging crosslinks between polypeptides. This 
means that in excess, PAMAM dendrimers are effectively ‘blocking’ the carboxyl groups 
from forming bridging crosslink by becoming pendant molecules. Similar observation 
was reported by Ma et al. when amino acids were used as crosslinking bridge for porous 
collagen scaffolds.
51
 The authors found that a NH2:COOH ratio of between 2-14 to be 
optimal for achieving stability with collagen scaffolds using a similar crosslinking system 
of EDC/ NHS.
51
 
It is interesting to note from Ts measurements (Figure 1) and collagenase 
degradation (Figure 5) that crosslinking reached a maximum with 0.7 mmoles of 
dendrimer. However, ATR-FTIR peak area ratios indicated a maximum utilization of –
COOH groups at 4.2 mmoles (Figure 2b). This observation can be explained as 0.7 
mmoles of dendrimer causes maximum number of crosslinking bridges and beyond 0.7 
mmoles, the tendency for formation of pendant PAMAM increases. At 4.2 mmoles of 
PAMAM, the –COOH could be completely utilized both by formation of crosslinking 
bridges as well as pendant PAMAM. Beyond 4.2 mmoles of PAMAM, the Ts and FTIR 
peak area ratios decreased (Figure 2b), while the amine content increased (Figure 3). That 
is, an increase in amine content is observed in spite of decrease in number of covalently 
bonded PAMAM molecules. This phenomenon could be due to inter-dendrimer 
interactions leading to the formation of oligomeric aggregates of PAMAM molecules at 
high concentrations. At high concentrations, the PAMAM molecules are reported to be 
involved in the formation of oligomeric aggregates by both non-specific repulsive 
interactions (steric plus electrostatic) as well as shorter range attractive interactions.
52,53
 
Thus, at high concentrations, the high molecular weight PAMAM oligomeric aggregates 
would be competing for the free –COOH groups on CEM. The bulkiness of PAMAM 
oligomers covalently bonded on the CEM could be involved in steric hindrance resulting 
in reduced crosslinking and under-utilization of –COOH groups. Furthermore, the 
oligomeric aggregates indicate an increase in the number of free amines as opposed to 
monomeric PAMAM at lower concentrations, explaining the increase in free amine 
content demonstrated by ninhydrin assay. 
The degree of swelling of a scaffold network is proportional to the amount of ions 
present in the network. Crosslinking a scaffold would decrease the swelling by restricting 
the polymer chain relaxation as well as by decrease in ionizable functional groups on the 
network. In the current study, we can expect an increase in swelling, as tethering 
multifunctional PAMAM dendrimer would increase the amount of ionizable –NH2 
groups in the CEM network. However, we did not see any statistical difference between 
the DENCEM scaffold variants (Figure 4). This could be due to the non-ionization of –
NH2 groups at pH 7.4 of the swelling buffer. 
The elastic moduli of crosslinked scaffolds were lower than that of non-
crosslinked CEM control, indicating that scaffolds were less stiff after the EDC/ NHS 
crosslinking process. The complex interactions between extracellular matrix and 
PAMAM dendrimer may confer the scaffold with increased extensibility without 
compromising tensile strength. This finding can be advantageous in clinical application 
where tensile strength and distensibility are essential but stiffness is undesirable, such as 
a scaffold for repair of the mobile anterior abdominal wall.
54,55
 The extent of crosslinking 
is generally believed to correspond to physical properties.
56
  The influence of EDC/ NHS 
crosslinking on mechanical properties of various collagen-based scaffolds has been 
studied with inconsistent results. While some studies showed improvement in tensile 
strength and stiffness with crosslinking treatment,
32,57
 others have shown the opposite or 
no effect.
31,38,58
 Duan et al. found that mechanical properties of collagen crosslinked with 
polypropyleneimine octaamine dendrimers was poor
59
 but improved dramatically by 
changing the collagen concentration.
24
 It may be that the concentration of EDC/ NHS 
used in this study was too low to produce any significant effect on tensile strength. 
Higher concentration of crosslinker might improve mechanical properties but at the 
expense of degradability. 
AlamarBlue
™
 and Hoechst DNA assays were used to assess metabolic activity 
and cell proliferation on cell-seeded scaffolds, respectively.
60-62
 Cells seeded on 
DENCEM scaffolds maintained their metabolic activity throughout the study period. 
Significant increase in the metabolic activity was observed with increasing culture time 
for DENCEM, EDCxCEM and non-crosslinked CEM (Figure 6). This finding was in 
contrast with the glutaraldehyde crosslinked negative control (GAxCEM), which showed 
a significantly lower metabolic activity. With increasing culture time, a significant 
reduction in activity was detected on GAxCEM. We have previously shown that 
glutaraldehyde crosslinking resulted in reduced cell activity compared to non-crosslinked 
CEM, and hence, the current effort to develop more cytocompatible crosslinking 
method.
29
 In addition, Hoechst DNA assay results showed that cells proliferated on the 
scaffolds (Figure 7). These results suggest that when PAMAM dendrimers were 
incorporated within CEM, their ability to support cell attachment and proliferation was 
similar to as seen with non-crosslinked CEM.
29
 In addition, the normal fibroblast 
morphology shown on SEM and fluorescent cell staining indicate that the cell phenotype 
was preserved (Figure 8). Blue fluorescence from cell nuclei was readily emitted after 
staining with DAPI, indicating abundance of DNA. Actin cytoskeleton was demonstrated 
by rhodamine phalloidin with concentration at the tips of the cell processes, presumably 
for cell to cell and cell to scaffold attachments. Cellular dendritic projections play a 
crucial role for cells in understanding the three dimensional environment and for cell to 
cell communications.
63
   
It should also be noted that scaffolds crosslinked with high quantity of PAMAM 
were still more stable compared to non-crosslinked CEM in both collagenase degradation 
and shrink temperature studies. This observation may be beneficial when designing 
scaffold with specific requirements. Modulation of conditions for PAMAM incorporation 
offers the opportunity to fabricate scaffold with a predefined degradation profile, shrink 
temperature and amine functional groups. When rapidly degrading scaffold is needed, 
high quantity of dendrimer can be used to provide the desired functional sites with the 
aim to deliver bioactive molecule. In contrast, when a prolonged scaffold presence is 
required in vivo, lower quantity of dendrimer can be incorporated into the scaffold while 
still maintaining grafting sites for bioactive molecules. Nevertheless, all crosslinked CEM 
scaffolds were eventually degraded and solublized in vitro by collagenase enzyme by the 
end of the study period of 72 hours. It is hypothesized that the difference in degradation 
profile will be more marked when these scaffolds are implanted in vivo and therefore, has 
potential for tailoring of in vivo degradation.  
In conclusion, incorporation of varied feed concentrations of PAMAM dendrimer 
in CEM using EDC/ NHS crosslinking system resulted in covalent binding of PAMAM 
on CEM. Varied degrees of crosslinking, improved stability of CEM to enzymatic 
degradation, increased amine functional groups useful in tethering bioactive agents, 
maintenance of tensile strength but increased flexibility of scaffold, as well as 
preservation of the ability of DENCEM to support cells in vitro were observed. These 
promising results justify the use of dendrimers as a strategy in designing degradable 
scaffold with predetermined biological functionality. Future studies would include using 
higher generation dendrimers that could provide higher degree of crosslinking and more 
free amine groups for subsequent modification. 
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TABLE 1 
 
Scaffold Types Ultimate Tensile 
Strength (UTS) (MPa) 
Modulus of 
Elasticity (MPa) 
Strain at UTS (%) 
CEM 3.4 ± 0.5 8.4 ± 2.3 
a
 32.0 ± 2.9
 a
 
EDCxCEM 2.6 ± 0.4 4.1 ± 0.4 
b
 56.9 ± 5.8
 b
 
DENCEM0.35 2.5 ± 0.6 5.1 ± 2.4 48.5 ±19.8
 b
 
DENCEM0.7 1.9 ± 0.7 4.2 ±1.1
 b
 48.9 ±10.9
 b
 
DENCEM2.1 2.7 ± 0.8 2.8 ± 0.5
 b
 50.8 ± 3.7 
b
 
DENCEM6.3 3.1 ± 0.4 1.3 ± 0.9
 b
 87.6 ±13.0
 b
 
a 
indicates statistically significant difference with
 b
 by ANOVA, p <0.05.
 
 
 
Table 1. Table showing mean values ± SD of ultimate tensile strength (UTS), modulus of 
elasticity and strain at UTS for the scaffold variants tested.  
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Figure 1. Shrink temperature measurements of CEM, EDCxCEM and DENCEM. (* *’, ¥ 
¥’, § §’) indicates statistical significance with each other. (ANOVA, p <0.05, n=3). 
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Figure 2. ATR-FTIR results showing (A) representative IR spectra for PAMAM 
dendrimer (DEN), CEM, DENCEM and EDCxCEM scaffolds and (B) the ratio of 
absorption intensity of 1631 cm
-1
 to 1735 cm
-1
 is plotted against the amount of PAMAM 
used for incorporation in CEM. * indicates statistical difference from the rest (ANOVA, p 
<0.05, n=3). 
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Figure 3. Free amine content measurements expressed in µg of glycine per mg of 
scaffold by ninhydrin method. (* *’, § §’) indicates statistically significant difference 
with each other by ANOVA (n=3). 
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Figure 4. Scaffold swelling behaviour shown as swelling ratio for CEM, EDCxCEM and 
DENCEM. § §’ indicates significant difference with each other (n=4). 
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Figure 5. Collagenase degradation assay of DENCEM, EDCxCEM and CEM scaffolds 
up to 72 hours in vitro. *∞ indicate significant difference in percentage weight remaining 
at 8 hours (ANOVA, p<0.05, n=3). 
 
 
FIGURE 6 
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Figure 6. AlamarBlue
™
 fluorescence optical density (OD) of fibroblast seeded test 
scaffolds compared to that on tissue culture plastic (TCP, positive control) and GAxCEM 
(negative control) as a function of time.  
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Figure 7. Hoechst DNA assay showing increase in DNA content from day 3 to day 6. 
With exception of negative control (GAxCEM), all scaffolds showed an increase in DNA 
content from day 3 to day 6. (**’) and (∞∞’) indicate statistically significant difference 
between groups.  
FIGURE 8 
 
Figure 8. SEM and photomicrographs of 3T3 fibroblasts seeded on scaffolds showing 
surface morphology and fluorescent staining (Rhodamine Phalloidin and DAPI) of 
cytoskeleton and nuclei. Fibroblasts with dendritic-like processes attaching to each other 
and surrounding extracellular matrix on (a & b) non-crosslinked CEM, (c) EDCxCEM, 
and (g & h) DENCEM2.1. Fibroblasts attached on extracellular matrix showing 
appearance of elongated cell body along direction of fibres on (d) EDCxCEM and (e & f) 
DENCEM0.7. 
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